K21 Improves Mitochondrial Function in Macrophages, Extending Life in Nematode Worms
Key claim: The antimicrobial K21 improves mitophagy and mitochondrial function in macrophages and extends lifespan when delivered to nematode worms.
Abstract
The antimicrobial drug K21 acts via disruption of bacterial membranes, but is also known to produce improved wound healing, which suggests the involvement of mechanisms other than antimicrobial activity. Here, K21 is shown to favorably modulate macrophage activity, in that exposure improves the operation of the mitochondrial quality control processes of mitophagy in macrophages, which in turn improves mitochondrial function. Delivery of K21 to nematode worms resulted in longer life spans, as one might expect from any intervention that improves mitochondrial function without meaningful side effects. Here, we sought to use single-cell RNA-seq to explore the diversity of the innate immune response and to understand its potential to be reprogrammed by antimicrobial therapy. Antimicrobials primarily target specific aspects of the pathogen’s lifecycle to inhibit its […]
Why this matters
K21 is being surfaced as an antimicrobial-repurposing candidate for the mitophagy-in-aged-macrophages axis, joining urolithin A, cyanidin chloride, and NAD precursors on the roster of small molecules claimed to remodel mitochondrial quality control in immune cells. The underlying evidence is cell-level plus nematode lifespan, with no mammalian bioenergetic or immune-aging endpoint, so the gap between the macrophage-mitophagy story and any human geroprotective pitch remains wide.